BoneCeramic™

BoneCeramic™

BoneCeramic™

Product catalog summary
Introduction
Straumann® BoneCeramic™ is a biocompatible alloplast designed to maintain bone volume while supporting gradual replacement by the patient's own bone. It is composed of hydroxylapatite and ß-tricalcium phosphate, providing a balance between preventing excessive resorption and allowing natural bone replacement.

Specifications
- Fully alloplastic biphasic calcium phosphate.
- Engineered to support restoration and preservation of bone volume.
- Gradually resorbs as it is replaced by new vital bone.

Performance and Flexibility
- Excellent handling characteristics and consistent quality due to its synthetic nature.
- Can be used alone or with autogenous bone.
- Suitable for various clinical applications such as peri-implant dehiscence defects, sinus lifts, and extraction sockets.

Clinical Data and Outcomes
- 28.35% average newly formed mineralized bone compared to 22.27% with bovine bone mineral, 6 to 8 months post-augmentation.
- 100% bone vitality in all cores harvested.
- Significant increase in mean bone area fraction over healing time when mixed with autogenous bone in sinus floor elevation.

Case Study: Sinus Elevation
- Demonstrates the use of BoneCeramic in sinus elevation procedures.
- Radiographs show the process from initial clinical situation to post-procedure outcomes.

Contact Information
For more information, contact Straumann Territory Manager or Customer Service. Purchase online at straumann.us/eShop or Straumann.ca/eShop.

Conclusion
Straumann® BoneCeramic™ offers a reliable and effective solution for bone regeneration, with proven clinical outcomes and flexibility to meet various clinical needs.
See more

Catalog excerpts

BoneCeramic™-1

BoneCeramic™ Data Sheet More than a synthetic solution. Straumann® BoneCeramic™ is a biocompatible and homogenous alloplast designed to maintain volume while supporting gradual replacement by your patient’s own bone. A fully alloplastic biphasic calcium phosphate, it’s composed of hydroxylapatite, which prevents excessive resorption and preserves bone volume, and ß-tricalcium phosphate, which absorbs more quickly as it’s replaced by natural bone. EFFECTIVE REGENERATION MATERIAL • ngineered to support restoration and preservation E of bone volume • Gradually resorbs as it is replaced by new vital bone DEPENDABLE PERFORMANCE • xcellent handling characteristics E FLEXIBILITY TO MEET CLINICAL NEEDS • an be used alone or in combination with C autogenous bone • Best suited for peri-implant dehiscence defects, fenestration defects, sinus lifts, extraction sockets, and horizontal augmentations SUPPORTS ONGOING BONE REGENERATION • 8.35 % average newly formed mineralized bone 2 versus 22.27 % with bovine bone mineral, 6 to 8 months post augmentation (p = 0.6024)1 • Trend of increase in mineral bone formation over healing time1 Image by Prof. Dr. S.J. Froum. Stevenel´s blue and Van Gieson´s picro fuchsin, magnification X 200. Reproduction authorized by International Journal of Periodontics & Restorative Dentistry. NMB: New mineralized bone SBC: Straumann BoneCeramic Polarized image displays osseointegration of Straumann BoneCeramic particle in lamellar type of bone, 6 months post augmentation Image by Prof. Dr. Z. Artzi. Paragon staining, original magnification X 600. Reproduction authorized by Clin. Oral Impl. Res. % 50 45 Percentage of augmented area • Consistent and reproducible quality because it’s totally synthetic Bone Particles Mean bone area fraction, post augmentation (Artzi Z et al.) • Bone vitality was 100% in all cores harvested1 • Significant increase in mean bone area fraction over healing time in a mix with autogenous bone, in sinus floor elevation2 Froum SJ et al. Histomorphometric comparison of a biphasic bone ceramic to anorganic bovine bone for sinus augmentation: 6- to 8- month postsurgical assessment of vital bone formation. A pilot study. Int J Periodontics Restorative Dent. 2008 Jun; 28(3): 273-81. Artzi Z et al. Histomorphometric assessment of bone formation in sinus augmentation utilizing a combination of autogenous and hydroxyapatite/biphasic tricalcium phosphate graft materials: at 6 and 9 months in humans. Clin. Oral Implants Res

 Open the catalog to page 1
BoneCeramic™-2

Radiograph shows pneumatized sinus Initial clinical situation Flap elevated, alveolar ridge visible and insufficient bone height for implant placement Window technique used to access the sinus floor Straumann BoneCeramic wetted with patient's blood BoneCeramic packed to the sinus through the opened window Radiograph shows the elevated floor after sinus floor elevation with BoneCeramic International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone: +41 (0)61 965 11 11 Straumann North American Headquarters Straumann USA, LLC www.straumann.us 60...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.